These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31750807)

  • 21. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of deep neuromuscular block on the surgeonś assessment of surgical conditions during laparotomy: a randomized controlled double blinded trial with rocuronium and sugammadex.
    Madsen MV; Scheppan S; Mørk E; Kissmeyer P; Rosenberg J; Gätke MR
    Br J Anaesth; 2017 Sep; 119(3):435-442. PubMed ID: 28969327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individual pharmacometric analysis for sugammadex reversal and re-administration of neuromuscular blockade.
    Kashima Y; Masui K
    J Anesth; 2020 Oct; 34(5):786-789. PubMed ID: 32656687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block.
    Martini CH; Boon M; Bevers RF; Aarts LP; Dahan A
    Br J Anaesth; 2014 Mar; 112(3):498-505. PubMed ID: 24240315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sugammadex ED90 dose to reverse the rocuronium neuromuscular blockade in obese patients.
    Silva MPD; Matsui C; Kim DD; Vieira JE; Malheiros CA; Mathias LAST
    Rev Col Bras Cir; 2017; 44(1):41-45. PubMed ID: 28489210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
    Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing the Heart Rate Effects From Administration of Sugammadex to Reverse Neuromuscular Blockade: An Observational Study in Patients.
    Ebert TJ; Cumming CE; Roberts CJ; Anglin MF; Gandhi S; Anderson CJ; Stekiel TA; Gliniecki R; Dugan SM; Abdelrahim MT; Klinewski VB; Sherman K
    Anesth Analg; 2022 Oct; 135(4):807-814. PubMed ID: 35759402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flucloxacillin and diclofenac do not cause recurrence of neuromuscular blockade after reversal with sugammadex.
    Kam PJ; Heuvel MW; Grobara P; Zwiers A; Jadoul JL; Clerck Ed; Ramael S; Peeters PA
    Clin Drug Investig; 2012 Mar; 32(3):203-12. PubMed ID: 22201295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A temporary decrease in twitch response following reversal of rocuronium-induced neuromuscular block with a small dose of sugammadex in a pediatric patient.
    Iwasaki H; Takahoko K; Otomo S; Sasakawa T; Kunisawa T; Iwasaki H
    J Anesth; 2014 Apr; 28(2):288-90. PubMed ID: 23963464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency estimation of sugammadex for the reversal of moderate rocuronium-induced neuromuscular block: a non-randomized dose-response study.
    Kitajima O; Yamamoto M; Takagi S; Suzuki T
    J Anesth; 2020 Jun; 34(3):348-351. PubMed ID: 32095883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
    Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
    Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between muscle mass ratio and rocuronium dose required for maintaining deep neuromuscular blockade: A prospective observational study.
    Han J; Oh AY; Hwang JW; Nam SW
    Anaesth Crit Care Pain Med; 2024 Jun; 43(3):101368. PubMed ID: 38460887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.